Description
The RANK ligand inhibitor denosumab as novel therapeutic agent in the spectrum of cancer bone disease
€3.03
The RANK ligand inhibitor denosumab as novel therapeutic agent in the spectrum of cancer bone disease
You must be logged in to post a review.
Reviews
There are no reviews yet.